公司資料
Dermata Therapeutics 股價、新聞與催化劑
- 股票代碼:
- DRMA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.46 USD (0.00%)
收盤價
最後更新: 2026年8月17日
5.47M USD
市值
股價為何變動
The latest monitored headline was “Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules”. DRMA was little changed in the corresponding trading session, closing at $1.46 on Aug 17, 2026.
公司概覽
Consumer Skincare Company
Dermata Therapeutics has shifted from clinical-stage dermatology development toward a direct-to-consumer commercial skincare strategy.
Tome Brand
Tome is designed as a professional-style at-home skincare line built around simplified, periodic treatments rather than multi-step daily regimens.
Foundational Treatment
The first product is a once-weekly mask intended to support skin renewal and serve as the foundation of the broader Tome portfolio.
未來催化劑
- Commercial launch of Tome Foundational Treatment on August 25, 2026.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。